SAN DIEGO--(BUSINESS WIRE)--Aegis Therapeutics LLC’s Intravail® transmucosal absorption enhancement technology has been selected as a winner in Pharmaceutical Technology's “Innovations in Pharma Science Awards.” Intravail® excipients make it possible to administer previously injectable-only drugs such as growth hormone, interferon, glucagon, and siRNA drugs through various non-invasive means including metered nasal sprays, flash dissolve buccal tablets, or oral formulations. Intravail® is featured in the December 2008 issue of Pharmaceutical Technology (Pharm Tech). Pharm Tech is a peer-reviewed publication serving 38,600 BPA-audited subscribers, the largest circulation in the industry, delivering practical, technical, and business-critical information to decision-makers in the pharmaceutical, biopharmaceutical, and manufacturing fields. It is available in a print version as well as an electronic version which may be accessed at http://www.pharmtech.com.
